Noninvasive measurement of cardiac output during 6-minute walk test by inert gas rebreathing to evaluate heart failure

Acta Cardiologica

Volumn 71, Issue 2, 2016, Pages 199-203

  Zhou, Suping ^a   Chen, Peng ^a   Li, Huijie ^a   Zeng, Chunyu ^a   Fang, Yuqiang ^a   Shi, Weibin ^a   Yang, Chengming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

6 minute walk test; Cardiac output; Heart failure; Inert gas rebreathing

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INERT GAS;

ADULT; ARTICLE; ATRIAL FIBRILLATION; BICYCLE EXERCISE TEST; BLOOD FLOW; BREATHING RATE; DIAGNOSTIC PROCEDURE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HUMAN; INERT GAS REBREATHING METHOD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REBREATHING; SIX MINUTE WALK TEST; VALVULAR HEART DISEASE; AGED; BREATH ANALYSIS; EXERCISE TEST; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; STATISTICS;

ADULT; AGED; BREATH TESTS; CARDIAC OUTPUT; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NOBLE GASES; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC;

EID: 84964034057     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.2143/AC.71.2.3141850     Document Type: Article

References (22)

1. Riley M, McParland J, Stanford CF, Nicholls DP. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 1992; 13: 789-93.
2. Gayda M, Temfemo A, Choquet D, Ahmaidi S. Cardiorespiratory requirements and reproducibility of the six-minute walk test in elderly patients with coronary artery disease. Arch Phys Med Rehabil 2004; 85: 1538-43.
3. Jehn M, Halle M, Schuster T, Hanssen H, Weis M, Koehler F, Schmidt-Trucksass A, The 6-min walk test in heart failure: is it a max or sub-maximum exercise test? Eur J Appl Physiol 2009; 107: 317-23.
4. Lang CC, Agostoni P, Mancini DM. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. J Card Fail 2007; 13: 672-9.
5. Van Laethem C, Van de Veire N, De Sutter J, Bartunek J, De Backer G, Goethals M, Vanderheyden M, Prospective evaluation of the oxygen uptake efficiency slope as a submaximal predictor of peak oxygen uptake in aged patients with ischemic heart disease. Am Heart J 2006; 152: 297. e9-e15.
6. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, Sperfeld A, Glaser S, Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803-9.
7. Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH. Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates. Circulation 2000; 101: 1152-7.
8. Goda A, Lang CC, Williams P, Jones M, Farr MJ, Mancini DM, Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure. Am J Cardiol 2009; 104: 1556-60.
9. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L, Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999; 33: 943-50.
10. Ho KK, Pinsky JL, Kannel WB, Levy D, The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A-13A.
11. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M, Greenberg B, Woods PA, Bourassa MG. Predication of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270: 1702-7.
12. Agostoni P, Cattadori G, Apostolo A, Contini M, Palermo P, Marenzi G, Wasserman K, Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 2005; 46: 1779-81.
13. Peyton PJ, Thompson B. Agreement of an inert gas rebreathing device with thermodilution and the direct oxygen Fick method in measurement of pulmonary blood flow. J Clin Monit Comput 2004; 18: 373-8.
14. Sobański P, Sinkiewicz W, Kubica J, Błazejewski J, Bujak R, The reliability of noninvasive cardiac output measurement using the inert gas rebreathing method in patients with advanced heart failure. Cardiol J 2008; 15: 63-70.
15. Hogenhuis J, Jaarsma T, Voors AA, Hillege HL, Lesman I, van Veldhuisen DJ, Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients. Int J Cardiol 2006; 18: 63-7.
16. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA, N-terminal pro-brain natriuretic peptide, a new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003; 24: 1735-43.
17. Wieczorek SJ, Hager D, Barry MB, Kearney L, Ferrier A, Wu AH, Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction. Clinica Chimica Acta 2003; 328: 87-90.
18. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN 3rd, Davis SF, Wilson JR, Hemodynamic exercise testing: a valuble tool in the selection of cardiac transplatation candidates. Circulation 1996; 94: 3176-83.
19. Lang CC, Karlin P, Haythe J, Lim TK, Mancini DM, Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail 2009; 2: 33-8.
20. Myers J. Exercise capacity and prognosis in chronic heart failure. Circulation 2009; 119: 3165-7.
21. Witte KK, Clark AL. Resting left ventricular function, however measured, is poorly related to exercise capacity in chronic heart failure. Am J Cardiol 2006; 98: 709-10.
22. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010; 3: 537-46.